Prudo-Chlebosz Raymond has filed 14 insider transactions across 1 company since May 2024.
Most recent transaction: a purchase of 618658 shares of Akari Therapeutics Plc ($AKTX) on December 16, 2025.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Director | P | Pre-Funded Warrants to purchase ADRs | 618658 | $0.40 | 618,658.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Director | P | Warrants to purchase American Depositary Shares ("ADRs") | 618658 | $0.00 | 618,658.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Director | P | Pre-Funded Warrants to purchase ADRs | 386661 | $0.40 | 386,661.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Director | P | Warrants to purchase ADRs | 386661 | $0.00 | 386,661.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| March 20, 2025 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2025 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | Series B Warrants (Right to Buy) | 446428 | $1.12 | 446,428.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | American Depositary Shares representing Ordinary Shares | 446428 | $1.12 | 2,904,728.0000 | 0 | 18.16% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | Series A Warrants (Right to Buy) | 446428 | $1.12 | 446,428.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2024 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | Ordinary Shares, par value $0.0001 per share | 419286000 | $0.00 | 4,916,600,800.0000 | 0 | 9.32% | 0.00% |
| Dec. 2, 2024 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | Warrants (Right to Buy) | 419286000 | $0.00 | 419,286,000.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | Stock Option (Right to Buy) | 10000000 | $0.00 | 10,000,000.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2024 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | Warrants (Right to Buy) | 1326258000 | $0.00 | 1,326,258,000.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2024 | Akari Therapeutics Plc | $AKTX | Prudo-Chlebosz Raymond | Not found | A | Ordinary Shares, par value $0.0001 per share | 1326258000 | $0.00 | 4,497,314,800.0000 | 0 | 41.82% | 0.00% |